Aetna to cover two weight loss drugs; Coventry shareholders approve buyout;

> Coventry Health Care's shareholders overwhelmingly voted to approve being acquired by Aetna. More than 99 percent of the almost 105 million shares voting favored the acquisition, which is expected to close mid-2013, reported the Washington Business Journal. Article

> Aetna has decided to cover two weight loss drugs, Qsymia and Bleviq, if they are considered "medically necessary" treatments for obese patients whose policies don't exclude such drugs, the Associated Press reported. Article

> A new report from the Catalyst for Payment Reform found that consolidation among providers is a "major driver" of healthcare costs. Report (.pdf)

And Finally… If you're sipping a cup of joe, you're probably smiling. Article